189 related articles for article (PubMed ID: 32474153)
1. Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells.
Satapathy SR; Sjölander A
Cancer Lett; 2020 Sep; 488():50-62. PubMed ID: 32474153
[TBL] [Abstract][Full Text] [Related]
2. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
Bellamkonda K; Satapathy SR; Douglas D; Chandrashekar N; Selvanesan BC; Liu M; Savari S; Jonsson G; Sjölander A
Cancer Lett; 2018 Nov; 437():13-24. PubMed ID: 30144515
[TBL] [Abstract][Full Text] [Related]
3. Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
Oncol Rep; 2018 Aug; 40(2):902-908. PubMed ID: 29845257
[TBL] [Abstract][Full Text] [Related]
4. CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer.
Savari S; Liu M; Zhang Y; Sime W; Sjölander A
PLoS One; 2013; 8(9):e73466. PubMed ID: 24039952
[TBL] [Abstract][Full Text] [Related]
5. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene D4 induces cellular senescence in osteoblasts.
Wei J; Chen S; Guo W; Feng B; Yang S; Huang C; Chu J
Int Immunopharmacol; 2018 May; 58():154-159. PubMed ID: 29587204
[TBL] [Abstract][Full Text] [Related]
7. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
8. [Effects of cysteinyl leukotriene receptors on phagocytosis of mouse microglial cells].
Wang X; Lu Y; Zhang W; Wei E; Fang S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):10-18. PubMed ID: 30146806
[TBL] [Abstract][Full Text] [Related]
9. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
11. DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients.
Ghatak S; Satapathy SR; Sjölander A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834820
[TBL] [Abstract][Full Text] [Related]
12. The tumor promoter cysteinyl leukotriene receptor 1 regulates PD-L1 expression in colon cancer cells via the Wnt/β-catenin signaling axis.
Satapathy SR; Ghatak S; Sjölander A
Cell Commun Signal; 2023 Jun; 21(1):138. PubMed ID: 37316937
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
14. Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor: does montelukast modulate antitumor and immunosuppressant effects of doxorubicin?
El-Sisi Ael-D; Sokar SS; Salem TA; Abu Risha SE
Toxicol Ind Health; 2015 Nov; 31(11):1024-36. PubMed ID: 26499992
[TBL] [Abstract][Full Text] [Related]
15. Montelukast attenuates interleukin IL-1β-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2).
Li Z; Wang J; Ma Y
Bioengineered; 2021 Dec; 12(1):8476-8484. PubMed ID: 34565285
[TBL] [Abstract][Full Text] [Related]
16. Antrodia cinnamomea Enhances Chemo-Sensitivity of 5-FU and Suppresses Colon Tumorigenesis and Cancer Stemness via Up-Regulation of Tumor Suppressor miR-142-3p.
Huang YJ; Yadav VK; Srivastava P; Wu AT; Huynh TT; Wei PL; Huang CF; Huang TH
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31349708
[TBL] [Abstract][Full Text] [Related]
17. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
[TBL] [Abstract][Full Text] [Related]
18. Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model.
Topi G; Satapathy SR; Dash P; Fred Mehrabi S; Ehrnström R; Olsson R; Lydrup ML; Sjölander A
J Pathol; 2020 Jul; 251(3):297-309. PubMed ID: 32333795
[TBL] [Abstract][Full Text] [Related]
19. Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation.
Kachi K; Kato H; Naiki-Ito A; Komura M; Nagano-Matsuo A; Naitoh I; Hayashi K; Kataoka H; Inaguma S; Takahashi S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299067
[TBL] [Abstract][Full Text] [Related]
20. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]